Publications by authors named "Ahmed Alaskar"

Claim this Profile
G
Genomics-driven drug repurposing and novel targets identification for sickle cell disease in Saudi patients.
Ali Alghubayshi, Mohammad A Alshabeeb, Dayanjan Wijesinghe, Mohammed AlAwadh, Suad Alshammari, Ahmed Alaskar

Front Bioinform· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adult genomic medicine: lessons from a multisite study of 2700 patients.
Khadijah Bakur, Halima Hamid, Bader Alhaddad, Majid Alfadhel, Amal Alhashem, Ahmed Alaskar

Genome Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of liver sinusoidal obstruction syndrome/veno-occlusive disease in adults: a 2025 perspective from an international expert group.
Marion Larue, Florent Malard, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat

Bone Marrow Transplant· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a comprehensive cancer control policy in Saudi Arabia.
Saleh A Alessy, Ali Al-Zahrani, Samar Alhomoud, Ahmed Alaskar, Abdelali Haoudi

Lancet Oncol· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Al Subait et al. Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds. 2025, , 736.
Arwa Al Subait, Raghad H Alghamdi, Rizwan Ali, Amani Alsharidah, Sarah Huwaizi, Ahmed Alaskar

Int J Mol Sci· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematological parameters' reference intervals in apparently healthy individuals in Saudi Arabia: a systematic review and meta-analysis.
Naila Shaheen, Seena Thomas, Areej Almoghairi, Ahmed Alaskar

Front Med (Lausanne)· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discontinuation of Tyrosine Kinase Inhibitor Therapy and Treatment Free Remission (TFR) in Chronic Myeloid Leukemia: Successful Achievement of TFR in More Than Two-Third of Patients in a Real-World Practice.
Aamer Aleem, Naila A Shaheen, Farjah Algahtani, Ahmed Jamal, Nora Alkhudair, Ahmed Alaskar

Clin Lymphoma Myeloma Leuk· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An international survey to better understand the current incidence, severity, and management of VOD/SOS.
Marion Larue, Myriam Labopin, Eolia Brissot, Ahmed S Alaskar, Mahmoud Aljurf

Bone Marrow Transplant· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of ABO Mismatch and Red Blood Cell Alloimmunization on the Outcome of Hematopoietic Cell Transplantation for Sickle Cell Disease.
Israa Saib, Bader Alahmari, Husam Alsadi, Ahmed Alaskar, Ayman Hejazi

Transplant Cell Ther· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Discovery of PPAR Alpha Lipid Pathway Modulators That Do Not Bind Directly to the Receptor as Potential Anti-Cancer Compounds.
Arwa Al Subait, Raghad H Alghamdi, Rizwan Ali, Amani Alsharidah, Sarah Huwaizi, Ahmed Alaskar

Int J Mol Sci· January 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Favorable outcome of non-myeloablative allogeneic transplantation in adult patients with severe sickle cell disease: A single center experience of 200 patients.
Moussab Damlaj, Bader Alahmari, Ahmed Alaskar, Ayman Alhejazi, Husam Alsadi

Am J Hematol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contemporary outcomes of high risk relapsed refractory classical hodgkin lymphoma patients-role of maintenance therapy in the real world.
Moussab Damlaj, Mohamed Tlayjeh, Ahmad Damlaj, Bader Alahmari, Husam AlSadi, Ahmed Alaskar

Bone Marrow Transplant· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Diagnosis and severity criteria for sinusoidal obstruction syndrome/veno-occlusive disease in adult patients: a refined classification from the European society for blood and marrow transplantation (EBMT).
Mohamad Mohty, Florent Malard, Ahmed S Alaskar, Mahmoud Aljurf, Mutlu Arat

Bone Marrow Transplant· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of a modified pediatric protocol versus a hyper-CVAD protocol in adolescents and young adults with Philadelphia-negative acute lymphoblastic leukemia: A multicenter retrospective analysis.
Hind Salama, Saleem Eldadah, Mohamed H Omer, Ayman Alhejazi, Luluh Bin Dayil, Ahmed Alaskar

Leuk Res· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Role of interim PET/CT as predictor of outcome in newly diagnosed diffuse large b-cell lymphoma in the chemo-immunotherapy era.
Moussab Damlaj, Waed Jaber, Afnan Al Najjar, Sumayyah Altamimi, Tarfa Al Onazi, Ahmed Alaskar

Curr Res Transl Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and Cytogenetic Characterization, and Outcome of Chronic Lymphocytic Leukemia Patients in a Single Tertiary Center in Saudi Arabia.
Areej Al Mugairi, Ekremah Alzarea, Abdulaziz Almosa, Feisal Alsomali, Abdulmajeed Alqahtani, Ahmed Alaskar

Clin Hematol Int· June 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
MICaFVi: A Novel Magnetic Immuno-Capture Flow Virometry Nano-Based Diagnostic Tool for Detection of Coronaviruses.
Nosaibah Samman, Kheireddine El-Boubbou, Khawlah Al-Muhalhil, Rizwan Ali, Ahmed Alaskar

Biosensors (Basel)· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiological outcome of bone disease in multiple myeloma patients pre- and post therapy: A single center experience.
Somaya A Aljohani, Israa H Saib, Ghulam Shah Syed, Ahmed Alruwaili, Shah P Numani, Ahmed S Alaskar

Saudi Med J· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rates and predictors of infusion-related reactions in patients receiving standard versus prolonged infusion of rabbit anti-thymocyte globulin for hematopoietic stem cell transplantation, a retrospective analysis.
Abdullah S Al Saleh, Abdulrahman I Alghamdi, Mohsen Alzahrani, Bader Alahmari, Ayman Alhejazi, Ahmed Alaskar

Bone Marrow Transplant· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematological indices in the adult saudi population: Reference intervals by gender, age, and region.
Naila A Shaheen, Hina Rehan, Areej Moghairi, Giamal Gmati, Moussab Damlaj, Ahmed S Alaskar

Front Med (Lausanne)· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of favipiravir in adults with mild COVID-19: a randomized, double-blind, multicentre, placebo-controlled clinical trial.
Mohammad Bosaeed, Ahmad Alharbi, Ebrahim Mahmoud, Sanaa Alrehily, Mohannad Bahlaq, Ahmed Alaskar

Clin Microbiol Infect· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HLA-identical related hematopoietic stem cell transplantation in severe sickle cell disease: age is not a barrier to successful outcome.
Mohsen Alzahrani, Moussab Damlaj, Mohammed Essa, Bader Alahmari, Ahmed Alaskar

Bone Marrow Transplant· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Feasibility of early sirolimus cessation post non-myeloablative transplantation in adult patients with severe sickle cell disease.
Moussab Damlaj, Bader Alahmari, Ahmed Alaskar, Ayman Alhejazi, Husam Alsadi

Bone Marrow Transplant· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Promising remissions in relapsed refractory classical Hodgkin lymphoma patients requiring multiple salvage regimens before transplantation in the brentuximab vedotin era.
Khadega A Abuelgasim, Samer Ghazi, Bader Alahmari, Ayman Alhejazi, Ahmed Alaskar

Leuk Res Rep· October 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis